| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.19 | 6e-06 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.23 | 4e-05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.19 | 7e-05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |